P. Michael McFadden

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Adjuvant chemotherapy for visceral pleural invasion in 3–4-cm non-small-cell lung cancer improves survival”.

Adjuvant chemotherapy for visceral pleural invasion in 3–4-cm non-small-cell lung cancer improves survival

European Journal of Cardio-Thoracic Surgery(2021)10.1093/ejcts/ezab498

N/A

0DataRank · unranked

11 citations

James Y Lee, Li Ding, Scott M. Atay, Kimberly A. Shemanski, P. Michael McFadden +3 more

Regional Variation in Treatment for Highest-Risk Patients With Non-Small Cell Lung Cancer

The Annals of Thoracic Surgery(2021)10.1016/j.athoracsur.2021.04.067

N/A

0DataRank · unranked

4 citations

Li Ding, Peggy J. Ebner, Anthony W. Kim, Scott M. Atay, Sean C. Wightman +4 more

Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapy

Journal of Thoracic Disease(2021)10.21037/jtd-21-110

N/A

0DataRank · unranked

2 citations

Li Ding, Elizabeth A. David, Sean C. Wightman, Scott M. Atay, P. Michael McFadden +2 more

Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer

JTCVS Open(2022)10.1016/j.xjon.2022.02.001

N/A

0DataRank · unranked

5 citations

Li Ding, Elizabeth A. David, Scott M. Atay, Sean C. Wightman, P. Michael McFadden +3 more